dr. reddy's laboratories news - Search News

Indian drugmaker Dr Reddy's shares slide

Hosted on MSN · 1d

Dr Reddy's Laboratories CEO: 'very positive outlook' for Indian pharma industry despite Trump 2.0

CEO of Dr Reddy's Laboratories, Erez Israeli believes his company's affordable medicines benefit the U.S. market and will be supported by the Trump administration. A strong U.S. dollar is bolstering earnings growth.

MarketWatch · 22h

Dr. Reddy's Laboratories underperforms Friday when compared to competitors

Dr. Reddy's Laboratories Ltd. 500124 shares slid 5.01% to 1,224.70 Indian rupees Friday, on what proved to be an all-around rough trading session for the stock market, with the BSE SENSEX Index 1 falling 0.

Indian drugmaker Dr Reddy's shares slide after Q3 profit miss

Shares of Dr Reddy's Laboratories dropped 6% in early trade on Friday, a day after the company reported a third-quarter profit that fell short of market estimates due to lower sales and pricing pressures in the key North American market.

1d

Dr. Reddy's Laboratories underperforms Thursday when compared to competitors

Dr. Reddy's Laboratories Ltd. 500124 shares inched down 0.54% to 1,289.35 Indian rupees Thursday, on what proved to be an all ...

2don MSN

Healthcare stocks rally over 2% as CLSA upgrades Dr Lal Pathlabs and Aurobindo; DRL drops on downgrade

Healthcare stocks see mixed performance as Dr Lal Pathlabs and Aurobindo Pharma rise over 2% after CLSA upgrades their ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results